[HTML][HTML] Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC: CBD extract and THC extract in …

JR Johnson, M Burnell-Nugent, D Lossignol… - Journal of pain and …, 2010 - Elsevier
OBJECTIVES: This study compared the efficacy of a tetrahydrocannabinol:cannabidiol (THC:CBD)
extract, a nonopioid analgesic endocannabinoid system modulator, and a THC extract…

Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer

NU Lin, V Diéras, D Paul, D Lossignol… - Clinical cancer …, 2009 - AACR
Purpose: Brain metastases develop in one third of patients with advanced HER2+ breast
cancer. Effective therapy for patients with central nervous system (CNS) progression after …

[HTML][HTML] An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with …

JR Johnson, D Lossignol, M Burnell-Nugent… - Journal of pain and …, 2013 - Elsevier
Context Chronic pain in patients with advanced cancer poses a serious clinical challenge.
The Δ9-tetrahydrocannabinol (THC)/cannabidiol (CBD) oromucosal spray (US Adopted Name…

[HTML][HTML] A little help from steroids in oncology

D Lossignol - Journal of translational internal medicine, 2016 - degruyter.com
Steroids are widely used in oncology and have been demonstrated to possess an anticancer
effect or antiswelling effect. They are considered to improve refractory symptoms such as …

Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis.

…, D de Valeriola, C Ravoet, D Lossignol… - Journal of clinical …, 1994 - ascopubs.org
PURPOSE This phase I study of Taxotere (RP 56976, NSC 628503; docetaxel, Rhône-Poulenc
Rorer, Antony, France) was undertaken to determine the maximum-tolerated dose (MTD)…

Successful use of ketamine for intractable cancer pain

DA Lossignol, M Obiols-Portis, JJ Body - Supportive care in cancer, 2005 - Springer
Goals and work Despite medical awareness, intractable pain is a serious problem in cancer
and occurs in up to 2% of advanced cancer patients. However, few data are available …

Opioid switch to oral methadone in cancer pain

I Mancini, DA Lossignol, JJ Body - Current Opinion in Oncology, 2000 - journals.lww.com
The occurrence of undesirable side effects due to opioids (delirium, confusion, myoclonus,
nausea, emesis) is one of the major complications in the management of pain, especially in …

Brain metastases in HER2-positive breast cancer: the evolving role of lapatinib

…, PL Bedard, E de Azambuja, D Lossignol… - Critical reviews in …, 2010 - Elsevier
Due to improvements in diagnosis and systemic therapy, brain metastases are an increasingly
common cause of morbidity and mortality for patients with advanced breast cancer. The …

Longitudinal follow-up of TTS-fentanyl use in patients with cancer-related pain: results of a compassionate-use study with special focus on elderly patients

J Menten, M Desmedt, D Lossignol… - Current medical research …, 2002 - Taylor & Francis
Goals of the work: This open compassionate-use prospective registration study evaluated
the tolerability, ease of use and applied doses of transdermal (TTS) fentanyl in adult patients …

Supportive/palliative care in cancer patients: quo vadis?

…, I Libert, B Michel, M Obiols, D Lossignol - Supportive care in …, 2016 - Springer
Supportive care in cancer has become a paradigm for the treatment in oncology. Now, we
have guidelines and active research in that field, making this area of clinical oncology both …